⚠ Evidence note: Nutrition evidence is dominated by observational data with heavy confounding; trial endpoints are mostly surrogates, not lifespan.
Food-Derived GLP-1R Agonists
Current understanding
Emerging preclinical work suggests certain edible plant compounds — notably citrus flavonoids from Changshan Huyou — can activate intestinal GLP-1 receptor signaling and reduce atherosclerotic and vascular-senescence endpoints in ApoE mice via the GLP-1R/PKA/CREB axis [animal-model]. No human trials yet demonstrate that dietary intake of these foods reproduces pharmacologic GLP-1RA effects on weight, glycemia, or cardiovascular outcomes; the framing as ‘natural GLP-1 agonists’ currently rests on rodent mechanism data [mechanism-plausible].
Evidence log
- 2026-07-30 — Complementary body weight and cardiometabolic benefits of higher GLP-1 and lower GIP: genetic evidence from large-scale phenomic analyses.: cross-connection with obesity-adiposity-aging: Genetic evidence that higher physiological GLP-1 lowers adiposity and cardiometabolic risk provides a target-validation backdrop for food-derived GLP-1R agonist research, though effect size from dietary modulation is unestablished. (novelty: 3)
- 2026-04-15 — Dietary geroprotective peptides: structural determinants, AI-driven discovery, and synthetic biology production for healthy ageing.: cross-connection with dietary-geroprotective-peptides: Both frame food-derived bioactive peptides as functional-food levers on aging-relevant pathways (IIS/mTOR vs. incretin signaling), sharing the AI-discovery and synthetic-biology production frame. (novelty: 3)
- 2026-08-05 — The Immunometabolic Bridge: Targeting Metainflammation to Prevent the Transition from Obesity to Cardiovascular Disease.: cross-connection with obesity-adiposity-aging: Review situates GLP-1 receptor agonism as a mid-tier intervention on the metainflammation-to-CVD pathway, linking adiposity biology to the GLP-1R agonist page. (novelty: 3)
- 2026-08-01 — Methionine tuning for health without frailty.: cross-connection with methionine-restriction: The proposed GH–GLP-1–FGF21 axis places endogenous GLP-1 signaling downstream of dietary methionine tuning, connecting amino-acid composition to the same incretin pathway targeted by food-derived GLP-1R agonists. (novelty: 3)
- 2026-08-05 — Citrus Changshan Huyou extracts as natural GLP-1R agonists attenuate atherosclerosis via the GLP-1R/PKA/CREB pathway: a functional food perspective.: cross-connection with food-medicine-homology-diet: Changshan Huyou is one of the listed medicine-food homology substances; provides a concrete mechanistic candidate within the broader pyramid framework. (novelty: 3)
Open questions
Related
Contributing findings
Citrus Changshan Huyou extracts as natural GLP-1R agonists attenuate atherosclerosis via the GLP-1R/PKA/CREB pathway: a functional food perspective.
05-aug-2026
novelty 3
per-area 3
introduces